The development of an effective vaccine has been hindered by the enormous diversity of
human immunodeficiency virus‐1 (HIV‐1) and its ability to escape a myriad of host immune …

The lentivirus human immunodeficiency virus (HIV) causes AIDS by interacting with a large
number of different cells in the body and escaping the host immune response against it. HIV …

Hydrogen peroxide and oxygen radicals are agents commonly produced during
inflammatory processes. In this study, we show that micromolar concentrations of H2O2 can …

A recombinant virus assay was used to characterize in detail neutralizing antibody
responses directed at circulating autologous HIV in plasma. Examining serial plasma …

Interaction with the CD4 receptor enhances the exposure on the human immunodeficiency
type 1 gp120 exterior envelope glycoprotein of conserved, conformation-dependent …

A newly-constructed antibody-like molecule containing the gp! 20-binding domain of the
receptor for human immunodeficiency virus blocks HIV-1 infection of T cells and monocytes …

Some HIV-1–infected patients develop broad and potent HIV-1 neutralizing antibodies
(bNAbs) that when passively transferred to mice or macaques can treat or prevent infection …

The rate of progression of HIV disease may be substantially different among HIV-infected
individuals. Following infection of the host with any virus, the delicate balance between virus …

Cell-cell adhesion is essential for many immunological functions1–4. The LFA-1 molecule, a
member of a superfamily of adhesion molecules, participates in adhesion which is critical to …

The primary event in the infection of cells by HIV is the interaction between the viral
envelope glycoprotein, gp120, and its cellular receptor, CD4. A recombinant form of gp120 …